Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Vaccination Status and Antibody Titers against Rubella and Measles among Japanese Female College Students Majoring in Childcare between 2015 and 2018.

Shoho Y, Kimura T, Yanagawa Y, Saito A, Inoue T, Suto C, Tsunekawa K, Araki O, Nara M, Tokue Y, Murakami M.

Tohoku J Exp Med. 2018 Oct;246(2):73-79. doi: 10.1620/tjem.246.73.

2.

Comparison of 16S ribosomal RNA gene sequence analysis and conventional culture in the environmental survey of a hospital.

Manaka A, Tokue Y, Murakami M.

J Pharm Health Care Sci. 2017 Jan 19;3:8. doi: 10.1186/s40780-017-0074-y. eCollection 2017.

3.

JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, Kasahara K, Kadota J, Kishida N, Kobayashi O, Sakata H, Seki M, Tsukada H, Tokue Y, Nakamura-Uchiyama F, Higa F, Maeda K, Yanagihara K, Yoshida K.

J Infect Chemother. 2016 Jul;22(7 Suppl):S1-S65. doi: 10.1016/j.jiac.2015.12.019. Epub 2016 Jun 15. No abstract available.

4.

Metallo-β-lactamase-producing Klebsiella pneumoniae infection in a non-hospital environment.

Okazaki R, Hagiwara S, Kimura T, Tokue Y, Kambe M, Murata M, Aoki M, Kaneko M, Oshima K, Murakami M.

Acute Med Surg. 2015 Apr 27;3(1):32-35. doi: 10.1002/ams2.120. eCollection 2016 Jan.

5.
6.

[The JAID/JSC Guideline to Clinical Management of Infectious Diseases (Respiratory infections)].

Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, Kasahara K, Kadota J, Kishida N, Kobayashi O, Sakata H, Seki M, Tsukada H, Tokue Y, Nakamura-Uchiyama F, Higa F, Maeda K, Yanagihara K, Yoshida K; Japanese Association for infectious diseases.

Kansenshogaku Zasshi. 2014 Jan;88(1):1-109. Japanese. No abstract available.

PMID:
24665586
7.

Seroprevalence of measles- and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007-2012.

Kimura T, Tsunekawa K, Ogiwara T, Tokue Y, Nara M, Inoue T, Obuchi T, Suto C, Ohshima K, Murakami M.

Jpn J Infect Dis. 2013;66(5):411-5.

8.

Tuberculosis screening using a T-cell interferon-γ release assay in Japanese medical students and non-Japanese international students.

Ogiwara T, Kimura T, Tokue Y, Watanabe R, Nara M, Obuchi T, Yaegashi A, Yomoda S, Ohshima K, Murakami M.

Tohoku J Exp Med. 2013 Jun;230(2):87-91.

9.

[Usefulness of sputum examination].

Tokue Y.

Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3510-5. Japanese. No abstract available.

PMID:
22338879
10.

Criteria for safety evaluation of antimicrobial agents.

Japanese Society of Chemotherapy; Antimicrobial Agents Safety Evaluation Standards Committee, Watanabe A, Tokue Y, Aoki N, Matsumoto T, Yanagihara K, Higa F, Tsuge H, Nagashima M, Matsuoka H, Sasagawa Y, Matsumoto M, Fujimaki K, Taguchi K, Ariyasu M, Yamamoto N, Kunii O, Shiba K.

J Infect Chemother. 2011 Feb;17(1):139-47. doi: 10.1007/s10156-010-0183-0. Epub 2011 Jan 6. No abstract available.

11.

Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007.

Gomi K, Fujimura S, Fuse K, Takane H, Nakano Y, Kariya Y, Kikuchi T, Kurokawa I, Tokue Y, Watanabe A.

J Infect Chemother. 2011 Apr;17(2):200-6. doi: 10.1007/s10156-010-0112-2. Epub 2010 Sep 14.

PMID:
20839026
12.

Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection.

Kikuchi T, Watanabe A, Gomi K, Sakakibara T, Nishimori K, Daito H, Fujimura S, Tazawa R, Inoue A, Ebina M, Tokue Y, Kaku M, Nukiwa T.

Thorax. 2009 Oct;64(10):901-7. doi: 10.1136/thx.2009.114603. Epub 2009 Jun 23.

PMID:
19553234
13.

In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin.

Fujimura S, Watanabe A, Fuse K, Kikuchi T, Gomi K, Tokue Y.

Int J Antimicrob Agents. 2008 Apr;31(4):391-2. doi: 10.1016/j.ijantimicag.2008.01.002. Epub 2008 Mar 4. No abstract available.

PMID:
18308516
14.

[Methicillin-resistant Staphylococcus aureus infection].

Tokue Y.

Nihon Rinsho. 2007 Mar 28;65 Suppl 3:414-7. Japanese. No abstract available.

PMID:
17491413
15.

Mouse and human cell activation by N-dodecanoyl-DL-homoserine lactone, a Chromobacterium violaceum autoinducer.

Gomi K, Kikuchi T, Tokue Y, Fujimura S, Uehara A, Takada H, Watanabe A, Nukiwa T.

Infect Immun. 2006 Dec;74(12):7029-31. Epub 2006 Sep 18.

16.

Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.

Watanabe A, Tokue Y, Kikuchi T, Gomi K, Aoki S, Satoh T, Fujimura S.

Int J Antimicrob Agents. 2005 Nov;26(5):420-3. Epub 2005 Oct 10. No abstract available.

PMID:
16216468
17.

Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.

Kikuchi T, Andarini S, Xin H, Gomi K, Tokue Y, Saijo Y, Honjo T, Watanabe A, Nukiwa T.

Infect Immun. 2005 Sep;73(9):5350-7.

18.

Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections.

Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T.

Chest. 2004 Jul;126(1):95-9.

PMID:
15249448
19.

Prevalence of community-acquired respiratory tract infections associated with Q fever in Japan.

Takahashi H, Tokue Y, Kikuchi T, Kobayashi T, Gomi K, Goto I, Shiraishi H, Fukushi H, Hirai K, Nukiwa T, Watanabe A.

Diagn Microbiol Infect Dis. 2004 Apr;48(4):247-52.

PMID:
15062916
20.

Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses.

Kikuchi T, Kobayashi T, Gomi K, Suzuki T, Tokue Y, Watanabe A, Nukiwa T.

J Immunol. 2004 Feb 1;172(3):1727-34.

21.

Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains.

Fujimura S, Tokue Y, Watanabe A.

Antimicrob Agents Chemother. 2003 Oct;47(10):3373-4. No abstract available.

22.

[Antibiotic susceptibility and beta-lactamase activity of pathogenic microbes isolated in Miyagi Prefecture between December in 1999 and February in 2000].

Watanabe A, Yasui S, Murayama Y, Tokue Y, Takahashi H, Kikuchi T, Gomi K, Kobayashi T, Fujimura S, Nukiwa T, Sato N, Saito M, Chiba J, Oikawa H, Sato T.

Jpn J Antibiot. 2002 Sep;55 Suppl A:42-53. Japanese.

PMID:
12599528
23.

Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.

Hagiwara K, Kikuchi T, Endo Y, Huqun, Usui K, Takahashi M, Shibata N, Kusakabe T, Xin H, Hoshi S, Miki M, Inooka N, Tokue Y, Nukiwa T.

J Immunol. 2003 Feb 15;170(4):1973-9.

24.

Severe acute interstitial pneumonia and gefitinib.

Inoue A, Saijo Y, Maemondo M, Gomi K, Tokue Y, Kimura Y, Ebina M, Kikuchi T, Moriya T, Nukiwa T.

Lancet. 2003 Jan 11;361(9352):137-9.

PMID:
12531582
25.

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors.

Kikuchi T, Hagiwara K, Honda Y, Gomi K, Kobayashi T, Takahashi H, Tokue Y, Watanabe A, Nukiwa T.

J Antimicrob Chemother. 2002 May;49(5):745-55.

PMID:
12003967
26.

Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000.

Watanabe A, Tokue Y, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S, Yasui S, Murayama Y, Nukiwa T.

J Infect Chemother. 2001 Dec;7(4):267-71.

PMID:
11810597
27.

Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years.

Watanabe A, Kikuchi H, Kikuchi T, Lutfor AB, Tokue Y, Takahashi H, Fujimura S, Shoji S, Honda Y, Nakai Y, Nukiwa T.

J Infect Chemother. 1999 Sep;5(3):171-175.

PMID:
11810511
28.

In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections.

Watanabe A, Kikuchi T, Lutfor AB, Tokue Y, Takahashi H, Fujimura S, Shoji S, Honda Y, Nakai Y, Nukiwa T.

J Infect Chemother. 1999 Sep;5(3):149-155.

PMID:
11810507
29.

High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.

Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H.

Antimicrob Agents Chemother. 2000 Dec;44(12):3441-3. Erratum in: Antimicrob Agents Chemother 2001 Feb;45(2):647.

30.

Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.

Fujimura S, Tokue Y, Takahashi H, Kobayashi T, Gomi K, Abe T, Nukiwa T, Watanabe A.

FEMS Microbiol Lett. 2000 Sep 15;190(2):299-303.

31.

Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens.

Watanabe A, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S, Tokue Y, Nukiwa T.

Chemotherapy. 2000 May-Jun;46(3):184-7.

PMID:
10765033
32.

[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].

Watanabe A, Tokue Y, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S, Yasui S, Nukiwa T, Shoji S, Honda Y.

Jpn J Antibiot. 1999 Dec;52(12):690-4. Japanese.

PMID:
10695024
33.

[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs].

Inoue M, Kubo S, Saito A, Ubukata K, Shimizu Y, Igari J, Watanabe A, Oguri T, Kawai T, Kobayashi Y, Hayashi M, Shiba K, Sakamoto M, Kanno H, Tokue Y, Yamaguchi K, Miyazaki S, Higashitsutsumi M, Sakamoto M, Inamatsu T, Kohno S, Tomono K, Shimada J, Kaku M, Ueda Y, et al.

Jpn J Antibiot. 1999 Apr;52(4):302-12. Japanese.

PMID:
10396687
34.

In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections.

Watanabe A, Tokue Y, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S, Nukiwa T.

Antimicrob Agents Chemother. 1999 Jul;43(7):1767-8.

35.
36.
37.

Comparative in vitro activity of vancomycin and other antimicrobial agents against methicillin-resistant staphylococcus aureus and enterococcus faecium in the Tohoku district of Japan.

Lutfor AB, Kikuchi T, Tokue Y, Takahashi H, Shoji S, Fujimura S, Nukiwa T, Watanabe A.

Chemotherapy. 1998 Sep-Oct;44(5):318-23.

PMID:
9732146
38.

A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.

Ando M, Watanabe T, Sasaki Y, Ying DF, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I, Taguchi T.

Br J Cancer. 1998 Jun;77(11):1937-43.

39.

CD44 variant isoform expression and breast cancer prognosis.

Tokue Y, Matsumura Y, Katsumata N, Watanabe T, Tarin D, Kakizoe T.

Jpn J Cancer Res. 1998 Mar;89(3):283-90.

40.

A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.

Fujimura S, Tokue Y, Takahashi H, Nukiwa T, Hisamichi K, Mikami T, Watanabe A.

J Antimicrob Chemother. 1998 Apr;41(4):495-7. No abstract available.

PMID:
9598784
41.

Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.

Takahashi H, Kikuchi T, Shoji S, Fujimura S, Lutfor AB, Tokue Y, Nukiwa T, Watanabe A.

J Antimicrob Chemother. 1998 Jan;41(1):49-57.

PMID:
9511037
42.

Colonoscopy for frank bloody stools associated with cancer chemotherapy.

Yokoyama T, Kondo H, Yokota T, Tokue Y, Saito D, Shimada Y, Sugihara K.

Jpn J Clin Oncol. 1997 Apr;27(2):111-4.

PMID:
9152801
43.

[Application of PCR to hospital epidemiology].

Tokue Y, Sugano K.

Tanpakushitsu Kakusan Koso. 1996 Apr;41(5):705-7. Review. Japanese. No abstract available.

PMID:
8650368
44.

DNA gyrase gyr A gene mutations in ofloxacin-resistant Staphylococcus aureus.

Tokue Y, Sugano K, Noda T, Saito D, Shimosato Y, Ohkura H, Kakizoe T, Sekiya T.

Int J Antimicrob Agents. 1995 Dec;6(2):123-6.

PMID:
18611696
45.

Identification of mycobacteria by nonradioisotopic single-strand conformation polymorphism analysis.

Tokue Y, Sugano K, Noda T, Saito D, Shimosato Y, Ohkura H, Kakizoe T, Sekiya T.

Diagn Microbiol Infect Dis. 1995 Dec;23(4):129-33.

PMID:
9407217
46.

Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones.

Takenouchi T, Ishii C, Sugawara M, Tokue Y, Ohya S.

Antimicrob Agents Chemother. 1995 Jul;39(7):1414-8.

47.

Eyelid metastasis from breast cancer showing marked response to chemotherapy.

Zhang GJ, Adachi I, Yin DF, Narabayashi M, Tokue Y, Watanabe T, Kaneko A, Tsuda H, Abe K.

Jpn J Clin Oncol. 1995 Feb;25(1):10-5. Review.

PMID:
7877258
48.

Tumor-associated Fever in Recurrent Breast Cancer with Liver Metastases.

Zhang GJ, Adachi I I, Okamoto R, Watanabe T, Narabayashi M, Tokue Y, Katsumata N.

Breast Cancer. 1994 Dec 30;1(2):145-150.

PMID:
11091523
49.

Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing.

Tokue Y, Sugano K, Saito D, Noda T, Ohkura H, Shimosato Y, Sekiya T.

Antimicrob Agents Chemother. 1994 Mar;38(3):428-31.

50.

[Clinical significance of respiratory infections associated with lung cancer patients].

Watanabe A, Nakai Y, Saito J, Honda Y, Tokue Y, Sugawara S, Numata Y, Kikuchi T, Sato J, Matsubara N.

Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Jul;30(7):1250-6. Japanese.

PMID:
1405100

Supplemental Content

Support Center